Lysophosphatidic acid induces glycodelin gene expression in cancer cells

Glycodelin is a glycoprotein that has been suggested to be important in normal pregnancy and in malignancy. The regulation of its synthesis has not been studied. In this study, we report the induction of glycodelin gene expression by lysophosphatidic acid (LPA). We studied the effect of LPA (5, 10 a...

Full description

Saved in:
Bibliographic Details
Published inCancer letters Vol. 177; no. 2; pp. 197 - 202
Main Authors Ramachandran, Sumathi, Ramaswamy, Sreemathy, Cho, Chi-heum, Parthasarathy, Sampath
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 28.03.2002
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0304-3835
1872-7980
DOI10.1016/S0304-3835(01)00807-2

Cover

More Information
Summary:Glycodelin is a glycoprotein that has been suggested to be important in normal pregnancy and in malignancy. The regulation of its synthesis has not been studied. In this study, we report the induction of glycodelin gene expression by lysophosphatidic acid (LPA). We studied the effect of LPA (5, 10 and 25 μM) on glycodelin production in breast (MDA-MB-231), cervical (Hela), endometrial (RL-95), ovarian cancer (OVCAR-3) and erythroleukemia (K562) cells. There was a dose-dependent (5–25 μM) induction of glycodelin gene and protein expression in these cell types. LPA is a mimic of phorbol myristate acetate (PMA) action and is found to be elevated in high concentrations in the serum of cancer subjects. As glycodelin is an angiogenic protein with a potential immunosuppressive role, control of LPA synthesis might offer a potential target for intervention.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0304-3835
1872-7980
DOI:10.1016/S0304-3835(01)00807-2